« Back
Home /
Olanzapine

Olanzapine

Item no.	TMO-T1567-25mg
Manufacturer	TargetMol
CASRN	132539-06-1
Amount	25 mg
Quantity options	100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 200 mg 25 mg 2 mg 500 mg 50 mg
Category	Metabolism Diabetes Glucose Homeostasis Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Citations	1. McDonald LM, et al. Psychopharmacology (Berl). 2003 Sep;169(3-4):321-31.
Smiles	CN1CCN(CC1)C1=NC2=C(NC3=C1C=C(C)S3)C=CC=C2
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	LY170053
Shipping Condition	Cool pack
Available
Manufacturer - Targets	Adrenergic Receptor\|\|\|Dopamine Receptor\|\|\|5-HT Receptor\|\|\|AChR
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	312.43
Description	Olanzapine (LY170053) is an atypical antipsychotic that is used currently in the treatment of schizophrenia and bipolar illness.
Pathways	GPCR/G Protein\|\|\|Neuroscience
Bioactivity	Olanzapine is an atypical antipsychotic, approved by the FDA in 1996. Olanzapine is manufactured and marketed by the pharmaceutical company Eli Lilly and Company, whose patent for olanzapine proper ends in 2011.
Receptor	5-HT; HT; mAChR; Adrenergic Receptor; Dopamine

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T1567-25mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 25 mg

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question